Summit Therapeutics, Inc. (SMMT)
15.83
-0.04
(-0.25%)
USD |
NASDAQ |
Feb 20, 12:35
Summit Therapeutics EPS Diluted (Quarterly) : -0.3118 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Exelixis, Inc. | 0.8849 |
| Insmed, Inc. | -1.538 |
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| Soleno Therapeutics, Inc. | 0.4736 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -231.79M |
| Total Expenses (Quarterly) | 231.79M |
| Enterprise Value | 11.58B |
| Earnings Yield | -7.84% |
| Normalized Earnings Yield | -7.845 |